Antiobesity activity of Vigna nakashimae extract in high-fat diet-induced obesity

Yonghae Son1, Jeong-Su Nam, Min-Kyung Jang

  • 1School of Korean Medicine, Pusan National University, Gyeongnam, South Korea.

Insights

Vigna nakashimae extract shows antiobesity effects by inhibiting fat cell differentiation and activating energy metabolism. This legume extract may serve as a dietary supplement for obesity prevention.

Area of Science:

  • Biochemistry
  • Metabolism
  • Pharmacology

Background:

  • Obesity is a complex metabolic disorder with significant health implications.
  • Dietary interventions are crucial for managing and preventing obesity.
  • Natural compounds are being explored for their potential antiobesity properties.

Purpose of the Study:

  • To evaluate the antiobesity effects of Vigna nakashimae (VN) extract.
  • To elucidate the molecular mechanisms underlying VN's antiobesity actions.
  • To assess VN's efficacy in both in vitro and in vivo models of obesity.

Main Methods:

  • In vitro studies using 3T3-L1 cells to assess adipocyte differentiation and gene expression.
  • In vivo studies using high-fat diet (HFD) induced obese mice.
  • Analysis of adipogenic and lipogenic gene expression, including peroxisome proliferator-activated receptor γ (PPARγ).
  • Assessment of AMP-activated protein kinase (AMPK) and acetyl CoA carboxylase (ACC) phosphorylation.
  • Measurement of body weight, fat tissue weight, hepatic lipid levels, and plasma lipid profiles.

Main Results:

  • VN extract suppressed adipocyte differentiation and key adipogenic gene expression in 3T3-L1 cells.
  • VN extract decreased PPARγ expression and its target genes while activating AMPK/ACC phosphorylation and fatty acid oxidation.
  • In HFD-fed mice, VN extract reduced body weight, fat accumulation, hepatic lipids, and plasma lipid levels.
  • VN extract normalized PPARγ expression and restored AMPK/ACC phosphorylation in vivo, consistent with in vitro findings.

Conclusions:

  • Vigna nakashimae extract possesses significant antiobesity effects.
  • The mechanisms involve suppression of PPARγ expression and activation of AMPK signaling pathways.
  • VN extract demonstrates potential as a natural dietary supplement for obesity prevention and management.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...